2022-01-06 General

Variants This preprint looks at the effectiveness of a COVID-19 infection (as opposed to a vaccination) against future COVID unpleasantness: Variant against infection against hospitalization or death Alpha 90.2% 69.4% Beta 84.8% 88.0% Delta 92.0% 100% Omicron 56.0% 87.8% This preprint says that most people have a quite good T-cell response to Omicron after a… Continue reading 2022-01-06 General

2021-12-29 General

Variants There continue to be studies in test tubes and lab rodents which all show pretty convincingly that Omicron does not infect the lungs as well as previous versions. This preprint says that T cells from vaccination still have 70-80% of their protection against Omicron (which is probably why breakthrough cases are mild). Transmission This… Continue reading 2021-12-29 General

2021-12-25/26/27/28 General

Variants There has been difficulty figuring out how badly Omicron is going to hit the hospital system first because it is a lagging indicator, second because Omicron affects vaccinated and unvaccinated people so differently, and third because of poor-quality data around the holidays. Still, there are hints that, as this tweet from New York says,… Continue reading 2021-12-25/26/27/28 General

2021-12-01 General

Transmission This article has some really cool pictures of some really really cool science. The study authors made a chemical/mechanical computer model of a virion inside an aerosol with water, lung fluid, mucous, and other crap that somebody might breathe out — 1.3 BILLION atoms worth — and then simulated it every millionth of a… Continue reading 2021-12-01 General

2021-11-30 General

Mitigation Measures This article describes tightened border controls in Canada in response to the threat of Omicron: Nigeria, Malawi and Egypt have been added to the list of restricted countries (South Africa, Mozambique, Namibia, Zimbabwe, Botswana, Lesotho and Eswatini were already on the list). Those who have been to any of their home countries in… Continue reading 2021-11-30 General

2021-11-18 General

Treatments This article talks about the good long-term results of AstraZeneca’s polyclonal antibody (brand name Evusheld). The article says it’s a two shot therapy like a vaccine, and given pre-exposure gives 83% protection over six months, sort of like a vaccine. Unlike a vaccine, however, it should work just as well in people who are… Continue reading 2021-11-18 General